New bid to curb doctors’ prescribing of hydroxychloroquine
Hydroxychloroquine scripts will be further restricted following sporadic shortages in Australia driven by apparent use of the agent to combat COVID-19.
The Federal Government has announced that from 1 May the PBS listing will change from ‘unrestricted’ to Authority Required (streamlined), following earlier moves to restrict initiation of the drug to a defined set of specialties, excluding GPs.